The Idiopathic Pulmonary Fibrosis Treatment Drug Market is expanding as pharmaceutical companies and healthcare providers prioritize improved solutions for patients affected by progressive respiratory diseases. Idiopathic pulmonary fibrosis is a complex condition involving irreversible lung tissue damage, creating a strong demand for therapies that can slow disease progression and enhance...